한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

포도잎추출물(HP-01)

포도잎추출물(HP-01)

MFDS recognition no.2022-31
Approval routeNotified (고시형) — listed in MFDS public standards
Daily intake (as approved)1800.0–1800.0 mg/일
Approval holder(유)한풍제약

Approved wording (Korean original)

혈소판 응집억제를 통한 혈행개선에 도움을 줌

Precautions (Korean original)

9. 섭취량, 섭취방법, 섭취시 주의사항 및 그 설정에 관한자료 참조
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.